HoxD9 Antibodies

Santa Cruz Biotechnology offers a broad range of HoxD9 monoclonal antibodies for research in developmental biology and gene regulation. HoxD9 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HoxD9 is a member of the homeobox gene family, which plays a critical role in regulating embryonic development and the formation of body structures. HoxD9 directs the specification of limb and axial structures, making it essential for proper morphogenesis. Understanding HoxD9 function can provide insights into developmental disorders and potential therapeutic targets. Research with HoxD9 monoclonal antibodies enables detailed investigation of developmental pathways and cellular differentiation. Studying HoxD9 expression patterns helps reveal mechanisms of tissue organization and organ development. Exploring HoxD9 activity advances knowledge of embryonic development and morphogenesis. Santa Cruz Biotechnology monoclonal antibodies for HoxD9 support researchers worldwide in advancing developmental biology and uncovering new therapeutic possibilities.